COST-EFFECTIVENESS ANALYSIS OF ROSUVASTATIN COMPARED TO ATORVASTATIN IN SPANISH PATIENTS AT MODERATE, HIGH, AND VERY HIGH CARDIOVASCULAR RISK

被引：0
|
作者：
Garcia-Goni, M. [1 ]
Facila, L. [2 ]
Cinza, S. [3 ]
Pinto, X. [4 ]
Cortes, X. [5 ]
Prades, M. [6 ]
Aceituno, S. [6 ]
机构：
[1] Univ Complutense, Madrid, Spain
[2] Hosp Gen Univ Valencia, Valencia, Spain
[3] Porto Do Son Primary Care Hlth Ctr, La Coruna, Spain
[4] Hosp Bellvitge Princeps Espanya, Lhospitalet De Llobregat, Spain
[5] Almirall SA, Barcelona, Spain
[6] Outcomes 10, Castellon De La Plana, Spain
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.620
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV74
引用
收藏
页码：S104 / S105
页数：3
相关论文
共 50 条
  • [21] Cost-effectiveness analysis of rosuvastatin in Greek patients with hyperlipidaemia
    Papageorgiou, M
    Karokis, A
    Plumb, JM
    Ratcliffe, A
    Southworth, H
    VALUE IN HEALTH, 2003, 6 (06) : 654 - 654
  • [22] A cost-effectiveness analysis of carotid artery stenting compared to endarterectomy in high risk populations
    Young, Kate C.
    Holloway, Robert G.
    Burgin, W. S.
    Benesch, Curtis G.
    CIRCULATION, 2008, 117 (21) : E425 - E425
  • [23] The cost-effectiveness of atorvastatin, rosuvastatin and simvastatin in treating patients to LDL-cholesterol targets
    Niskanen, L.
    Peura, P. K.
    Hallinen, T.
    Soini, E.
    Martikainen, J.
    EUROPEAN HEART JOURNAL, 2007, 28 : 860 - 860
  • [24] Cost-effectiveness in Italy of preventive treatment with ramipril in patients at high risk of cardiovascular events
    Capri, S
    Perlini, S
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (06) : 913 - 921
  • [25] Profile of evolocumab and its cost-effectiveness in patients with high cardiovascular risk: literature review
    Jankovic, Slobodan M.
    Tesic, Danka
    Andelkovic, Jelena
    Kostic, Marina
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2018, 18 (05) : 461 - 474
  • [26] COST-EFFECTIVENESS OF ICOSAPENT ETHYL FOR PATIENTS AT HIGH CARDIOVASCULAR RISK WITH ELEVATED TRIGLYCERIDES IN GREECE
    Stratopoulos, A.
    Kougioumtzoglou, I
    Mortaki, K.
    Rigopoulos, P.
    Jakouloff, D.
    VALUE IN HEALTH, 2023, 26 (12) : S51 - S51
  • [27] Cost-effectiveness of pharmacist care for managing patients at high risk for cardiovascular disease in Canada
    Al Hamarneh, Y. N.
    Johnston, K.
    Marra, C.
    Tsuyuki, R.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 297 - 298
  • [28] A COST EFFECTIVENESS ANALYSIS OF ROSUVASTATIN AGAINST ATORVASTATIN IN CARDIOVASCULAR DISEASES AND STROKE: AN AMBISPECTIVE STUDY
    Deepthy, B.
    VALUE IN HEALTH, 2016, 19 (07) : A653 - A653
  • [29] Cost-Effectiveness Analysis of Ezetimibe as the Add-on Treatment to Moderate-Dose Rosuvastatin versus High-Dose Rosuvastatin in the Secondary Prevention of Cardiovascular Diseases in China: A Markov Model Analysis
    Yang, Han
    Li, Nan
    Zhou, Youlian
    Xiao, Zhilan
    Tian, Haoming
    Hu, Ming
    Li, Sheyu
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 157 - 165
  • [30] Cost-effectiveness analysis of romosozumab for severe postmenopausal osteoporosis at very high risk of fracture in Mexico
    Martinez, Juan Pablo Diaz
    de Maraumont, Therese Aubry
    Sanchez, Elly Natty
    Cordero, Luis Miguel Camacho
    Yeh, Eric
    PLOS ONE, 2025, 20 (02):
12345